GI
ABMD

Gradient Investments’s Abiomed Inc ABMD Stock Holding History

Gradient Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed -$1K – 1698
2022
Q3 		$1K Buy
+3
New +$810 ﹤0.01% 1327
2019
Q4 		– Sell
-29
Closed -$5K – 1282
2019
Q3 		$5K Hold
29
– – ﹤0.01% 812
2019
Q2 		$8K Buy
+29
New +$7.69K ﹤0.01% 714
2019
Q1 		– Sell
-14
Closed -$5K – 1042
2018
Q4 		$5K Buy
+14
New +$4.86K ﹤0.01% 722

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gradient Investments's ABMD Position: Q4 2022 in Review

Gradient Investments sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3 shares — an estimated $1K sold.

Gradient Investments first reported a position in ABMD in Q4 2018 and held it in 4 quarters. The position peaked at $8K in Q2 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Gradient Investments reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Gradient Investments sold 3 Abiomed Inc shares in Q4 2022, an estimated $1K.
  • Gradient Investments first reported a position in Abiomed Inc in Q4 2018 and held it in 4 quarters.
  • Gradient Investments's Abiomed Inc position peaked at $8K in Q2 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Gradient Investments's 13F filing for Q4 2022, filed 10 Jan 2023.